Genesis Robotic System Marks its Debut Clinical Performance

Stereotaxis announced the successful premiere of its Genesis Robotic Magnetic Navigation System, having been used by physicians at Erasmus University Medical Center in Rotterdam, The Netherlands.

“We have long recognized the clinical benefits of robotics, and are delighted to be the first in The Netherlands to make the Genesis robotic system available to cardiovascular patients,” said Dr. Sing-Chien Yap, director of Electrophysiology at Erasmus Medical Center. “We are impressed with the speed and responsiveness of Genesis. Combined with the MAGiC Catheter we are particularly pleased with the synergistic additive improvements to robotic magnetic navigation. These technological advances are important in ensuring we can offer the best care to all arrhythmia patients, including children, patients with congenital heart disease, and patients with complex arrhythmia.”

Erasmus MC has used robotic magnetic navigation for complex arrhythmia procedures for quite some time, having performed more than 4,500 procedures with Stereotaxis technology. The Genesis System— considered the latest advancement in robotic magnetic navigation technology—has introduced the benefits of robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias. Tens of millions of individuals worldwide suffer from arrhythmias—abnormal heart rhythms that result when the heart beats too quickly, too slowly, or with an irregular pattern. When left untreated, arrhythmia may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

“We appreciate our long-term partnership with the electrophysiology team at Erasmus,” Stereotaxis Chairman/CEO David Fischel stated. “We look forward to continuing to support their successful robotic program and working together to advance technological progress, scientific discovery, and clinical care.”

Stereotaxis develops surgical robotics solutions for minimally invasive endovascular intervention. It discovers, develops, and delivers robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat more than 150,000 patients in the United States, Europe, Asia, and elsewhere.